A previous study confirmed STEAP2 was downregulated in breast cancer, and its upregulation inhibited tumor proliferation, invasion, and metastasis by suppressing PI3K-Akt signaling pathway in vitro and in vivo [43]. Here, STEAP2 is linked to neoplasm.